Innovative applications of artificial intelligence during the COVID-19 pandemic

The COVID-19 pandemic has created unprecedented challenges worldwide. Artificial intelligence (AI) technologies hold tremendous potential for tackling key aspects of pandemic management and response. In the present review, we discuss the tremendous possibilities of AI technology in addressing the global challenges posed by the COVID-19 pandemic. First, we outline the multiple impacts of the current pandemic on public health, the economy, and society. Next, we focus on the innovative applications of advanced AI technologies in key areas such as COVID-19 prediction, detection, control, and drug discovery for treatment. Specifically, AI-based predictive analytics models can use clinical, epidemiological, and omics data to forecast disease spread and patient outcomes. Additionally, deep neural networks enable rapid diagnosis through medical imaging. Intelligent systems can support risk assessment, decision-making, and social sensing, thereby improving epidemic control and public health policies. Furthermore, high-throughput virtual screening enables AI to accelerate the identification of therapeutic drug candidates and opportunities for drug repurposing. Finally, we discuss future research directions for AI technology in combating COVID-19, emphasizing the importance of interdisciplinary collaboration. Though promising, barriers related to model generalization, data quality, infrastructure readiness, and ethical risks must be addressed to fully translate these innovations into real-world impacts. Multidisciplinary collaboration engaging diverse expertise and stakeholders is imperative for developing robust, responsible, and human-centered AI solutions against COVID-19 and future public health emergencies.

Artificial intelligence: Machine learning approach for screening large database and drug discovery

Recent research in drug discovery dealing with many faces difficulties, including development of new drugs during disease outbreak and drug resistance due to rapidly accumulating mutations. Virtual screening is the most widely used method in computer aided drug discovery. It has a prominent ability in screening drug targets from large molecular databases. Recently, a number of web servers have developed for quickly screening publicly accessible chemical databases. In a nutshell, deep learning algorithms and artificial neural networks have modernised the field. Several drug discovery processes have used machine learning and deep learning algorithms, including peptide synthesis, structure-based virtual screening, ligand-based virtual screening, toxicity prediction, drug monitoring and release, pharmacophore modelling, quantitative structure-activity relationship, drug repositioning, polypharmacology, and physiochemical activity. Although there are presently a wide variety of data-driven AI/ML tools available, the majority of these tools have, up to this point, been developed in the context of non-communicable diseases like cancer, and a number of obstacles have prevented the translation of these tools to the discovery of treatments against infectious diseases. In this review various aspects of AI and ML in virtual screening of large databases were discussed. Here, with an emphasis on antivirals as well as other disease, offers a perspective on the advantages, drawbacks, and hazards of AI/ML techniques in the search for innovative treatments.

Data Mining, Quality and Management in the Life Sciences

With the evermore emphasis put on open science and its invaluable benefits to the scientific community, it is no longer the case where a research project simply ends with a scientific publication. The benefits of data sharing and reproducibility of results have taken the centerpiece within the life science research supported by FAIR principles that firmly underline the importance of open data. The current data-intensive multidisciplinary research has also highlighted the significance of how data is mined and managed. Here we describe some of the features adopted by EMBL-EBI data resources to support data mining, data quality, and data management. We also highlight how EMBL-EBI has responded to the current pandemic through its data resources.

A Keyword-Based Literature Review Data Generating Algorithm—Analyzing a Field from Scientific Publications

A scientific review is a type of article that summarizes the current state of a specific field, which is crucial for promoting the advancement of our science community. Authors need to read hundreds of research articles to prepare the data and insights for a comprehensive review, which is time-consuming and labor-intensive. In this work, we present an algorithm that can automatically extract keywords from the meta-information of each article and generate the basic data for review articles. Two different fields—communication engineering, and lab on a chip technology—were analyzed as examples. We first built an article library by downloading all the articles from the target journal using a python-based crawler. Second, the rapid automatic keyword extraction algorithm was implemented on the title and abstract of each article. Finally, we classified all extracted keywords into class by calculating the Levenshtein distance between each of them. The results demonstrated its capability of not only finding out how communication engineering and lab on a chip were evolved in the past decades but also summarizing the analytical outcomes after data mining of the extracted keywords. Our algorithm is more than a useful tool for researchers during the preparation of a review article, it can also be applied to quantitatively analyze the past, present and help authors predict the future trend of a specific research field.

The European Bioinformatics Institute in 2020: building a global infrastructure of interconnected data resources for the life sciences

Data resources at the European Bioinformatics Institute (EMBL-EBI, https://www.ebi.ac.uk/) archive, organize and provide added-value analysis of research data produced around the world. This year's update for EMBL-EBI focuses on data exchanges among resources, both within the institute and with a wider global infrastructure. Within EMBL-EBI, data resources exchange data through a rich network of data flows mediated by automated systems. This network ensures that users are served with as much information as possible from any search and any starting point within EMBL-EBI's websites. EMBL-EBI data resources also exchange data with hundreds of other data resources worldwide and collectively are a key component of a global infrastructure of interconnected life sciences data resources. We also describe the BioImage Archive, a deposition database for raw images derived from primary research that will supply data for future knowledgebases that will add value through curation of primary image data. We also report a new release of the PRIDE database with an improved technical infrastructure, a new API, a new webpage, and improved data exchange with UniProt and Expression Atlas. Training is a core mission of EMBL-EBI and in 2018 our training team served more users, both in-person and through web-based programmes, than ever before.